This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Pierre Barratt
Director CMC at LGC



For the past nine years I have worked within LGC's rapidly expanding Drug Development Solutions division firstly as a Principal Scientist and now the Director CMC in the US focusing on GMP Grade Nucleic Acid Therapeutics . As a leading independent provider of analytical testing services and reference materials to the pharmaceutical and healthcare industries, LGC work strategically with our customers to support their research and development, quality assurance and regulatory activities.

Prior to LGC, I worked as a Senior Scientist for Pfizer Global R & D (13 years) providing significant contribution to drug development teams as analytical team leader for projects at varying stages of development. These projects were delivered through extensive knowledge of my own preferred subject areas (Analytical Chemistry/Physical Properties) and wide understanding of the pharmaceutical R & D process. By maintaining effective partnerships with colleagues in Pharmaceutical Sciences, Clinical Sciences, Regulatory CMC, Legal and Manufacturing ensured key milestones for clinical studies, regulatory submissions and commercial milestones were met.

My education has been completed in parallel with my career through day release or distance learning; BSc in Chemistry, MSc in Pharmaceutical Sciences concluding with an MBA.

Agenda Sessions

  • LGC’s NAT Extended Services: Physicochemical Property Characterization of an Oligonucleotide